English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/187475
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Differential effects of a glucagon-like peptide 1 receptor agonist in non-alcoholic fatty liver disease and in response to hepatectomy

AuthorsValdecantos, M. P.; Ruiz, Laura; Pardo, Virginia; Castro-Sánchez, Luis; García-Monzón, Carmelo; Lanzón, Borja; Rupérez, Francisco J.; Barbas, Coral; Naylor, Jaqueline; Trevaskis, James L.; Grimsby, J.; Rondinone, Cristina M.; Valverde, Ángela M.
Issue Date2018
PublisherSpringer Nature
CitationScientific Reports 8: 16461 (2018)
AbstractNon-alcoholic fatty liver disease (NAFLD) is associated with post-operative liver failure (PLF) and impaired liver regeneration. We investigated the effects of a glucagon-like peptide-1 (GLP-1) receptor agonist on NAFLD, PLF and liver regeneration in mice fed chow diet or methionine/choline-deficient diet (MCD) or high fat diet (HFD). Fc-GLP-1 decreased transaminases, reduced intrahepatic triglycerides (TG) and improved MCD-induced liver dysfuction. Macrophage/Kupffer cell-related markers were also reduced although Fc-GLP-1 increased expression of genes related to natural killer (NK), cytotoxic T lymphocytes and hepatic stellate cell (HSC) activation. After partial hepatectomy (PH), survival rates increased in mice receiving Fc-GLP-1 on chow or MCD diet. However, the benefit of Fc-GLP-1 on NASH-like features was attenuated 2 weeks post-PH and liver mass restoration was not improved. At this time-period, markers of NK cells and cytotoxic T lymphocytes were further elevated in Fc-GLP-1 treated mice. Increased HSC related gene expression in livers was observed together with decreased retinyl ester content and increased retinal and retinoic acid, reflecting HSC activation. Similar effects were found in mice fed HFD receiving Fc-GLP-1. Our results shed light on the differential effects of a long-acting GLP-1R agonist in improving NAFLD and PLF, but not enhancing liver regeneration in mice.
Publisher version (URL)https://doi.org/10.1038/s41598-018-33949-z
URIhttp://hdl.handle.net/10261/187475
DOI10.1038/s41598-018-33949-z
E-ISSN2045-2322
Appears in Collections:(IIBM) Artículos
Files in This Item:
File Description SizeFormat 
differhepate.pdf8,35 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.